StreetInsider.com News Articles

NHI Announces Third Quarter 2026 Earnings Release and Conference Call Dates

Wed, 07 Oct 2026 06:00:00 -0400

MURFREESBORO, Tenn., Oct. 7, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2026. NHI plans to issue its earnings release after the market closes on Monday, November 9, 2026, and will host a conference call on the following day, Tuesday, November 10, 2026, at 10:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference

NHI Announces Third Quarter 2026 Earnings Release and Conference Call Dates

Wed, 07 Oct 2026 06:00:00 -0400

NHI acquires six senior housing properties for $107.7 million

Thu, 01 Oct 2026 07:01:57 -0400

National Health Investors, Inc. (NYSE: NHI) acquired six senior housing properties totaling 443 units across Kentucky, Michigan, and Tennessee for $107.7 million, including transaction costs, according to a press release.

The properties will be added to NHI's Senior Housing Operating Portfolio (SHOP) segment and managed by Allegro Living Management, an affiliate of existing NHI partner Allegro Living. The communities are expected to generate an initial net operating income (NOI) yield of approximately 7.0%, or 6.6% after routine capital expenditures. NHI expects to invest an additional $2.3 million in the properties during the first year.

NHI also reported approximately $164.3 million in investment

NHI Announces $107.7 Million SHOP Investment

Thu, 01 Oct 2026 07:00:00 -0400

MURFREESBORO, Tenn., Oct. 1, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE:NHI) announced today that it invested $107.7 million, including transaction costs, for the acquisition of six properties with 443 units in Kentucky, Michigan and Tennessee. NHI expects to make an additional investment of $2.3 million during the first year.

NHI Announces $107.7 Million SHOP Investment

Thu, 01 Oct 2026 07:00:00 -0400

BMO Capital on National Health Investors (NHI): 'Acquisitions Accelerating; SHOP Growth Execution Key'

Wed, 23 Sep 2026 08:54:02 -0400

BMO Capital analyst Juan C. Sanabria reiterated an Outperform rating and $80.00 price target on National Health Investors (NYSE: NHI).

The analyst commented: "Acquisitions Accelerating; SHOP Growth Execution Key; We hosted positive investor meetings with Eric Mendelsohn (President/CEO), Kevin Pascoe (CIO), Todd Siefert (CFO) and Dana Hambly (SVP Finance). NHI is focused on returning to FAD/sh growth via its SHOP portfolio where non-same store NOI growth is meeting expectations (high-single-digits/low-double-digits), as well as via acquisitions. Acquisition yields are compressing with competition (Yr-1: low-to-mid 6%), but the opportunity set remains robust with closings set to accelerate. Post NHC exit related underperformance, valuation

NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline

Mon, 14 Sep 2026 16:05:00 -0400

MURFREESBORO, Tenn., Sept. 14, 2026 /PRNewswire/ -- National Health Investors, Inc. (NYSE: NHI) announced today that management will participate in investor meetings at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026.

NHI to Participate in the BofA Securities 2026 Global Real Estate Conference; Updates Pipeline

Mon, 14 Sep 2026 16:05:00 -0400

Huntington Starts National Health Investors (NHI) at Outperform

Wed, 09 Sep 2026 16:20:40 -0400

Huntington analyst Rob Stevenson initiates coverage on National Health Investors (NYSE: NHI) with a Outperform rating and a price target of $79.00.

For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.

Shares of National Health Investors closed at $71.42 yesterday.

National Health Investors (NHI) PT Lowered to $80 at Truist Securities

Wed, 02 Sep 2026 09:32:15 -0400

(Updated - September 2, 2026 9:32 AM EDT)

Truist Securities analyst Michael Lewis lowered the price target on National Health Investors (NYSE: NHI) to $80.00 (from $81.00) while maintaining a Buy rating.

The analyst commented: "Lowering FFO Estimates and Price Target to $80 from $81, But Maintaining Buy Rating; What’s Incremental to Our View: We are lowering our 2026 and 2027 FFO estimates following a $0.07ps miss versus our model in 2Q26 (half of which was related to the CFO transition and deferred income tax expense). Our 12-month price target of $80 (was $81) implies roughly one turn of FFO multiple expansion

National Health Investors (NHI) PT Lowered to $80 at Truist Securities

Wed, 02 Sep 2026 09:32:15 -0400

(Updated - September 2, 2026 9:32 AM EDT)

Truist Securities analyst Michael Lewis lowered the price target on National Health Investors (NYSE: NHI) to $80.00 (from $81.00) while maintaining a Buy rating.

National Health Investors (NHI) PT Lowered to $78 at Wells Fargo

Tue, 01 Sep 2026 06:49:08 -0400

Wells Fargo analyst John Kilichowski lowered the price target on National Health Investors (NYSE: NHI) to $78.00 (from $79.00) while maintaining a Equal Weight rating.

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 27

Thu, 27 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260827/26989923.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 27

Thu, 27 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260827/26989923.html

Form 144 NATIONAL HEALTH INVESTOR Filed by: Spaid John L

Mon, 17 Aug 2026 11:16:00 -0400

si-local-file:///var/storage/secattach/20260817/26936542.html

Form 144 NATIONAL HEALTH INVESTOR Filed by: Spaid John L

Mon, 17 Aug 2026 11:16:00 -0400

si-local-file:///var/storage/secattach/20260817/26936542.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260810/26898171.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260810/26898171.html

National Health Investors (NHI) Tops Q2 EPS by 28c

Mon, 10 Aug 2026 16:15:41 -0400

National Health Investors (NYSE: NHI) reported Q2 EPS of $1.15, $0.28 better than the analyst estimate of $0.87. Revenue for the quarter came in at $68.9 million versus the consensus estimate of $71.52 million.

For earnings history and earnings-related data on National Health Investors (NHI) click here.

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260810/26898028.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260810/26898028.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260810/26897981.html

Form 8-K NATIONAL HEALTH INVESTOR For: Aug 10

Mon, 10 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260810/26897981.html

Form 10-Q NATIONAL HEALTH INVESTOR For: Jun 30

Mon, 10 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260810/26897951.html

Form 10-Q NATIONAL HEALTH INVESTOR For: Jun 30

Mon, 10 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260810/26897951.html